OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Infectious Diseases is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination	65
Skin manifestations of Pseudomonas aeruginosa infections	57
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection	38
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections	31
Antimicrobial-resistant bacteria in international travelers	29
Parental vaccine hesitancy: scope, causes, and potential responses	27
Techniques in bacterial strain typing: past, present, and future	26
Long COVID in children and adolescents	26
Choosing antibiotic therapy for severe community-acquired pneumonia	23
Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis	22
Zoonoses and global epidemics	22
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections	21
Viral meningitis and encephalitis: an update	21
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	20
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy	20
New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections	20
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	19
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	19
Emerging treatment options for cryptosporidiosis	19
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination	18
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	18
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	18
MDRO transmission in acute hospitals during the COVID-19 pandemic	18
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	18
Hospital water as the source of healthcare-associated infection and antimicrobial-resistant organisms	18

Staphylococcus aureus infections in children	17
New testing guidelines for community-acquired pneumonia	17
Gram-negative endocarditis: disease presentation, diagnosis and treatment	17
Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials	16
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity	15
Coronavirus disease 2019 vaccination in transplant recipients	15
Typhoid fever control in the 21st century: where are we now?	15
COVID-19 transmission and the safety of air travel during the pandemic: a scoping review	14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	14
Respiratory metagenomics: route to routine service	14
Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections	14
Dengue vaccine development: challenges and prospects	14
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	13
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts	13
Mycobacterial skin infection	13
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients	13
Skin manifestations in patients with coronavirus disease 2019	13
mRNA vaccines against respiratory viruses	12
Management dilemmas in Nocardia brain infection	12
Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges	12
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls	12
Long-acting injectable HIV therapies: the next frontier	12
Frailty in people living with HIV: an update	12
Cytomegalovirus in primary immunodeficiency	12
Siderophores: a potential role as a diagnostic for invasive fungal disease	12
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	12
Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment	11
Neurologic aspects of coronavirus disease of 2019 infection	11
Respiratory syncytial virus infection in the modern era	11
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	10
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	10
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	10
Hyperammonemia syndrome in immunosuppressed individuals	10
Neurodevelopmental outcomes in congenital and perinatal infections	10
Echocardiography and FDG-PET/CT scan in Gram-negative bacteremia and cardiovascular infections	10
Pneumonia in older adults	10
Nontyphoidal Salmonella infections acquired from poultry	9
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections	9
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	9
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections	9
Dose optimisation of antibiotics used for meningitis	9
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	9
Neuroradiology of infectious diseases	9
Immunotherapeutic approaches to HIV cure and remission	9
Emergence of a novel urogenital-tropic Neisseria meningitidis	9
Antiviral therapies for influenza	9
Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections	9
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions	8
Neurobrucellosis	8
The disease burden of respiratory syncytial virus in older adults	8

Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia	8
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	8
Conjunctival cancer in people living with HIV	8
Neurocysticercosis: an update on diagnosis, treatment, and prevention	8
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	8
Bacterial RTX toxins and host immunity	8
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications	8
Current international and national guidelines for managing skin and soft tissue infections	7
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?	7
Congenital cytomegalovirus infection diagnostics and management	7
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	7
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?	7
Arboviral central nervous system infections	7
Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections	7
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	7
Current opinion in management of septic shock due to Gram-negative bacteria	7
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	7
Molecular diagnostic methods for pneumonia: how can they be applied in practice?	7
Tick-borne encephalitis	7
Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts	7
Biomarkers in sepsis: can they help improve patient outcome?	7
The role of Gram-negative bacteria in skin and soft tissue infections	7
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Coronavirus disease 2019 in children	7
Neonatal bloodstream infections	7
Skin and soft tissue infections due to rapidly growing mycobacteria	7
Pregnancy and malaria: the perfect storm	7
Antimicrobial use in central nervous system infections	7
Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient − clinical spectrum and outcome	7
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges	7